首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Distinct Functional Domains Contribute to Degradation of the Low Density Lipoprotein Receptor (LDLR) by the E3 Ubiquitin Ligase Inducible Degrader of the LDLR (IDOL)
【2h】

Distinct Functional Domains Contribute to Degradation of the Low Density Lipoprotein Receptor (LDLR) by the E3 Ubiquitin Ligase Inducible Degrader of the LDLR (IDOL)

机译:不同的功能域有助于通过E3泛素连接酶诱导的LDLR(IDOL)降解降解低密度脂蛋白受体(LDLR)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We recently identified the liver X receptor-regulated E3 ubiquitin ligase inducible degrader of the LDL receptor (IDOL) as a modulator of lipoprotein metabolism. Acting as an E3 ubiquitin ligase, IDOL triggers ubiquitination and subsequent degradation of the low density lipoprotein receptor (LDLR). We demonstrate here that this outcome requires the conserved FERM and RING domains present in IDOL. The RING domain promotes ubiquitination in vitro and Lys-63-specific ubiquitination of the LDLR in vivo in response to IDOL or liver X receptor activation. We further identify RING residues that differentially influence ubiquitination of the LDLR or stability of IDOL. The FERM domain interacts with the LDLR and in living cells co-localizes with the receptor at the plasma membrane. Homology modeling revealed a phosphotyrosine-binding element embedded in the FERM domain. Mutating residues within this region or residues in the LDLR preceding the NPVY endocytosis motif abrogate LDLR degradation by IDOL. Collectively, our results indicate that both the FERM and RING domains are required for promoting lysosomal degradation of the LDLR by IDOL. Our findings may facilitate development of structure-based IDOL inhibitors aimed at increasing LDLR abundance in therapeutic strategies to treat cardiovascular disease.
机译:我们最近确定了肝脏X受体调节的LDL受体(IDOL)的E3泛素连接酶诱导型降解子作为脂蛋白代谢的调节剂。 IDOL充当E3泛素连接酶,触发泛素化并随后降解低密度脂蛋白受体(LDLR)。我们在此证明,此结果需要IDOL中存在的保守FERM和RING域。响应IDOL或肝X受体激活,RING域可促进体外泛素化和体内LDLR的Lys-63特异性泛素化。我们进一步确定了RING残基,这些残基差异性地影响LDLR的泛素化或IDOL的稳定性。 FERM结构域与LDLR相互作用,并且在活细胞中与质膜上的受体共定位。同源性建模揭示了嵌入FERM域中的磷酸酪氨酸结合元件。在NPVY内吞作用基序之前,该区域内的突变残基或LDLR中的残基消除了IDOL对LDLR的降解。总的来说,我们的结果表明,FERM和RING域都是促进IDOL促进LDLR溶酶体降解的必需条件。我们的发现可能有助于开发基于结构的IDOL抑制剂,旨在在治疗心血管疾病的治疗策略中增加LDLR的丰度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号